Global Organ Preservation Solution Market Share Report 2024, Forecast To 2033
8 Mar, 2024
The organ preservation solution market has demonstrated steady growth, increasing from $274.48 billion in 2023 to $295.92 billion in 2024, with a compound annual growth rate (CAGR) of 7.8%. This growth is attributed to factors such as rise in organ transplants and growing awareness of organ donation. Looking forward, the market is poised for continued strong growth, reaching $406.07 billion by 2028, with a CAGR of 8.2%. Emerging trends such as application of preservation solutions in organ banking are expected to drive this growth, alongside major trends including focus on extended preservation times and integration of additives for enhanced preservation.
Global Organ Preservation Solution Market Key Driver
The rise in organ transplantation is anticipated to propel growth in the organ preservation solution market. With a growing number of transplants performed annually, there is an increasing need for effective preservation methods. Data from the Organ Procurement and Transplantation Network highlights the steady growth in organ transplants, driving demand for preservation solutions. Therefore, the increasing prevalence of organ transplantation drives the expansion of the organ preservation solution market.
Get A Free Sample Of The Global Organ Preservation Solution Market ReportGlobal Organ Preservation Solution Market Segments
The organ preservation solution market covered in this report is segmented –
1) Solution Type:Viaspan, Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate), Renograf, Hypothermosol, Perfadex, Lifor, HBS (Hyperosmotic Blood Substitute) Solution, siRNA (Small Interfering RNA) Transplant Solutions, Other Solution Types
2) Organ Type:Kidneys, Liver, Lung, Heart, Other Organ Types
3) Technique:Static Cold Storage (SCS) Technique, Hypothermic Machine Perfusion, Other Techniques
By Geography: The countries covered in the organ preservation solution market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the organ preservation solution market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organ preservation solution market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Organ Preservation Solution Industry Players
Bristol-Myers Squibb Company; Baxter International Inc.; Teva Pharmaceutical Industries Ltd.; Accord Healthcare; BioLife Solutions Inc.; Lifeline Scientific; TransMedics Group Inc.; XVIVO Perfusion AB; Organ Recovery Systems Inc.; Bridge to Life Ltd.; Paragonix Technologies Inc.; OrganOx Limited; BioTime Inc.; Shanghai Genext Pharmaceutical Technology; 21st Century Medicine; Institut Georges Lopez; Carnamedica; Global Transplant Solutions; Preservation Solutions Inc.; Essential Pharmaceuticals LLC; Dr. Franz Köhler Chemie GmbH; Advanced Organ Preservation Solutions (OPSL Group); Vascular Perfusion Solutions Inc.; Transplant Biomedicals SL; Claris Lifesciences Limited
Get The Full Global Organ Preservation Solution Market Report
Organ Preservation Solution Market Overview
Organ preservation solutions are specially formulated solutions used to preserve organs during transplantation or storage. These solutions serve to safeguard organs from potential damage during the transplantation procedure and prolong the duration for which organs can be stored outside of the body. They may consist of specific agents designed to mitigate ischemia-reperfusion injury (IRI) by employing targeted mechanisms of action.